Success Story: Advancing AI-Assisted Biomedical Discovery Leads to NIW Approval for a Computational Biomedicine Researcher
Client’s Testimonial:
"Recommended by my lab mates and many PhD students around me, WeGreen proved to be a highly regarded and professional firm with clear strategic guidance throughout the application process. The approval-or-refund policy they offered for my case, along with the professional team supporting the case (including a dedicated person following the case and a separate team conducting multiple rounds of review before submission), really inspired confidence."
On May 1st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student Researcher in the Field of Computational Biomedicine (Approval Notice).
General Field: Computational Biomedicine
Position at the Time of Case Filing: Graduate Student Researcher (PhD Candidate)
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: May 1st, 2026
Processing Time: 3 months, 16 days (Premium Processing Upgrade Requested)
Case Summary:
AI-driven healthcare depends on models that can detect subtle biological patterns across complex data. In computational biomedicine, this work is especially important because stronger machine learning methods can support earlier screening, more accurate diagnosis, and deeper insight into the molecular origins of disease. That was the foundation of this I-140 NIW approval.
The client, an expert in computational biomedicine, received I-140 NIW approval based on his proposed endeavor to develop statistical machine learning methods and deep learning models capable of identifying subtle, high-dimensional signals across diverse genomics and biomedical data. His work supports applications ranging from disease mechanism discovery to preventive screening and AI-assisted diagnosis.
Rather than presenting the case as a general AI profile, the petition demonstrated the client’s significance by connecting his methods to concrete national priorities in healthcare innovation, genomic medicine, and diagnostic improvement. We explained how his research advances the accuracy and stability of AI tools for biomedical data analysis, supports public health goals, and contributes to critical and emerging technology areas recognized as important to U.S. scientific leadership.
To show that the client was well-positioned to advance this endeavor, we documented a strong record of scholarly production, independent reliance, and peer trust. His achievements included:
- 7 peer-reviewed journal articles, including 2 first-authored publications, along with 2 conference abstracts, 2 preprints, and 1 patent application.
- 124 citations, showing that other researchers have relied on his methods and findings in computational biomedicine, biomedical imaging, genomics, and AI-assisted diagnosis.
- At least 8 completed peer reviews, demonstrating that journals and conferences trusted him to evaluate advanced work in his field.
- Research supported by major funding sources, including the National Science Foundation and the National Institutes of Health.
Importantly, the petition did not treat these numbers as self-evidently sufficient. Instead, we explained how an adjudicator could view the evidence as showing influence beyond routine publication. Client’s publications included papers in prestigious journals as well as several that were cited at unusually high rates for their publication year and field, including work ranked among the top 1% or top 10% most-cited articles in relevant comparisons. This helped show that his contributions were not only published, but also actively used by other researchers.
The petition also emphasized the broader reach of his work through open-source tools and computational methods that can be adopted by researchers beyond his own workplace. This accessibility strengthened the argument that his research benefits a wider biomedical and technological ecosystem, including academic, clinical, and industry settings.
This approval reflects the strength of a carefully prepared NIW petition grounded in technical depth, independent validation, and national relevance. We were pleased to help secure this result for a computational biomedicine researcher whose work supports more accurate, scalable, and AI-assisted approaches to biomedical discovery and healthcare in the United States.